A stem cell derived investigational therapy for treating Parkinson’s disease has shown promise in early clinical trials. BlueRock Therapeutics, a subsidiary of Bayer, has announced details of the positive data…
A considerable roadblock in the successful triaging of new therapeutics for liver and metabolic related diseases is the reliability and effectiveness of pre-clinical disease models. Methods employing animal models may…
…neurodegenerative diseases like Alzheimer’s; including positive clinical trial results for new immunotherapy and biotherapeutic candidates, and hopes that existing medications could slow the progression of dementia. The top stories: Could…
Educational campaign, Clinical Trials For All, has been launched to drive greater understanding, participation and diversity in clinical trials. Only 59% of Americans know about clinical research, 91% of Americans…
…and Moffitt Cancer Center. It blends DiMe’s expertise in convening cross-disciplinary groups to develop clinical-quality resources on a tech timeline with Moffitt’s top research and care experts. The initiative is…
The Phase I clinical trial of VENT-02, an oral, brain-penetrant NLRP3 inhibitor from Ventus Therapeutics, has launched with the dosing of the first patient. Based on the safety margins demonstrated…
…the Phase IIa clinical trial data in The Lancet’s eBioMedicine (Volume 94, 104665, August 2023), stating that UB-311 was safe and well-tolerated. UB-311 is a synthetic, peptide-based active immunotherapy that…
…your compound helps you avoid unnecessary clinical studies, costs, delays and more. This webinar will provide insights at a high-level related to regulatory drivers, investigatory objectives, and practical concerns for…
…The new tablet formulation of SFX-01 will now replace the prototype capsule for future regulatory submissions and clinical trials. Edited by Diana Spencer, Senior Digital Content Editor, Drug Discovery World…
Bloom Science has announced positive topline data from a Phase I clinical trial of BL-001, a potential first-in-class therapeutic the company is developing for Dravet syndrome and amyotrophic lateral sclerosis…
…on the latest industry updates. Diana Spencer has chosen news stories this week which all discuss pre-clinical research studies that could have a huge impact on our therapeutic approach to…
…shown in the SELECT trial, an effect that was also shown in clinical trials in 2022. It is currently under investigation in various other clinical trials, for example, as a…
…for conditions such as rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD). Preclinical data supports new approach to Alzheimer’s disease Preclinical data has demonstrated that the oral small molecule…
…Spikevax, Moderna’s Covid-19 vaccine, to target XBB variants with speed and clinical rigor,” said Stéphane Bancel, CEO of Moderna. “We have been working diligently for months to build ample supply,…
